NORTRIPTYLINE 10 MG
NORTRIPTYLINE (NORTRIPTYLINE HYDROCHLORIDE) : 10 MG · DIN 02223139 · APOTEX INC
Health Canada status: APPROVED
What is NORTRIPTYLINE?
NORTRIPTYLINE 10 MG contains NORTRIPTYLINE (NORTRIPTYLINE HYDROCHLORIDE) : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02223139, held by APOTEX INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as approved, status dated 06-Apr-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02223139 |
|---|---|
| Brand name | NORTRIPTYLINE |
| Generic / active ingredient | NORTRIPTYLINE (NORTRIPTYLINE HYDROCHLORIDE) : 10 MG |
| Manufacturer | APOTEX INC |
| Strength | 10 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N06AA10 NORTRIPTYLINE |
| AHFS class | 28:16.04.28 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 06-Apr-2021 |
What can be used instead?
Other Canadian products sharing ATC code N06AA10 NORTRIPTYLINE. 2 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AVENTYL | 10 MG | CAPSULE | AA PHARMA INC | MARKETED | DIN 00015229 |
| AVENTYL | 25 MG | CAPSULE | AA PHARMA INC | MARKETED | DIN 00015237 |
| APO-NORTRIPTYLINE | 10 MG | CAPSULE | APOTEX INC | DORMANT | DIN 02223511 |
| APO-NORTRIPTYLINE | 25 MG | CAPSULE | APOTEX INC | DORMANT | DIN 02223538 |
| AVA-NORTRIPTYLINE | 10 MG | CAPSULE | AVANSTRA INC | CANCELLED POST MARKET | DIN 02364301 |
| AVA-NORTRIPTYLINE | 25 MG | CAPSULE | AVANSTRA INC | CANCELLED POST MARKET | DIN 02364328 |
| DOM-NORTRIPTYLINE 10MG CAPSULES | 10 MG | CAPSULE | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02178729 |
| DOM-NORTRIPTYLINE 25MG CAPSULES | 25 MG | CAPSULE | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02178737 |
| GEN-NORTRIPTYLINE CAPSULES 10MG | 10 MG | CAPSULE | GENPHARM ULC | CANCELLED POST MARKET | DIN 02231686 |
| GEN-NORTRIPTYLINE CAPSULES 25MG | 25 MG | CAPSULE | GENPHARM ULC | CANCELLED POST MARKET | DIN 02231687 |
Who else supplies NORTRIPTYLINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. NORTRIPTYLINE appears in 12 registered pack listings across 4 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.